INDY-AUTONOMOUS-CHALLENG
16.7.2024 16:01:31 CEST | Business Wire | Press release
On a busy Sunday afternoon, in front of a global audience of motorsport enthusiasts, The Indy Autonomous Challenge’s (IAC) self-driving AV-24 racecar set the record for the fastest autonomous Hillclimb at the Festival of Speed. The AV-24 is piloted by an AI Driver developed by Team PoliMOVE-MSU (Politecnico di Milano and Michigan State University).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240716347266/en/
The IAC AV-24, a racecar driven by AI, sets autonomous record at the Goodwood Festival of Speed. (Photo: Business Wire)
The AV-24 performed a series of three runs during the iconic festival. The record was broken during their third and final run up the Goodwood Hill where the racecar reached a top speed of 111.2 mph (179 kph) and a finish time of 66.37 secs. The record-setting run can be watched here. The previous record has been held by Roborace since 2019 when their “DevBot 2.0” autonomous car clocked a 66.96 sec time at a top speed of 101.16 mph (162.8 kph).
Goodwood is known for its unforgiving narrow course, lined with hay bells and limited run-off space. Attempting an autonomous hill climb at the Festival of Speed required absolute control of grip and slippage from the AV-24’s Bridgestone racing tires as well as precision mapping and localization in a GPS limited environment resulting in a higher than usual reliance on the AV-24’s Luminar Iris lidars.
The IAC and PoliMOVE-MSU teams worked closely with Bridgestone’s tire engineers to optimize performance ahead of the Hillclimb including traveling to Bridgestone’s European Technical Center and European Proving Grounds in Rome. The team also had the unique chance to explore each step of tire production and test how impactful tire performance is on track.
Paul Mitchell, Chairman and President of the IAC: “For three years, the IAC has been pushing the boundaries of high-speed autonomy and setting new records along the way. The Goodwood Hillclimb is a historic backdrop with huge crowds and a global audience that is now aware of the potential of self-driving vehicles to be safely deployed on roads in the future.”
Professor Sergio Savaresi, PoliMOVE-MSU Team Principal: “This challenge represents an important milestone for autonomous mobility. This weekend we overcame significant challenges posed by a complicated track and temperamental weather patterns. Thanks to the exceptional work and skills implemented by our engineering team and tire performance ensured by our Bridgestone racing tires, we made history by showing the public that safe and high-speed vehicular autonomy is possible even in adverse conditions. Our record at the Goodwood Festival of Speed will inspire confidence in future autonomous driving applications.”
Sara Correa, Chief Marketing Officer for Bridgestone in the Americas, Europe, Middle East and Africa (EMEA) added, “Bridgestone is proud to support the PoliMOVE-MSU team in this incredible achievement at the Goodwood Festival of Speed 2024. We are committed to partnering with the IAC and its inspiring student engineers to continue testing and improving autonomous technologies in record-setting runs like this and beyond. Motorsports are part of Bridgestone’s DNA, always have been and always will be. And what really matters is that we take the learnings from experiences like this and apply them to the sustainable mobility solutions we develop for society and our customers.”
Visuals and footage including of the IAC’s Autonomous Hillclimb can be found here.
About the IAC: The Indy Autonomous Challenge (IAC) is a non-profit corporation based in Indianapolis, Indiana (USA) that organizes racing competitions among 10 university-affiliated teams representing 18 universities from around the world. Teams program AI drivers to pilot fully autonomous racecars and compete in a series of history-making events at iconic tracks. The IAC is working to establish a hub for performance automation in the state and is harnessing the power of innovative competitions to attract the best and the brightest minds from around the globe to further state-of-the-art technology in the safety and performance of autonomous vehicles. The IAC started as a $1 million prize competition with 31 university teams signing up to compete more than three years ago, representing top engineering and technology programs from 15 U.S. states and 11 countries. Follow the IAC @IndyAChallenge on LinkedIn, Twitter, Instagram, Facebook, & YouTube.
About Bridgestone: Bridgestone is a global leader in tires and rubber building on its expertise to provide solutions for safe and sustainable mobility. Headquartered in Tokyo, the company employs approximately 130,000 people globally, conducting business in more than 150 countries and territories worldwide. Bridgestone offers a diverse product portfolio of premium tires and advanced solutions backed by innovative technologies, improving the way people around the world move, live, work and play.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240716347266/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom